COVID-19 Pipeline of Small and Mid-Cap Bio/Pharma Companies - Coronavirus Disease 2019 Sector Forecast

2020-07-30
Price :
Published : Jul-2020
No. of Pages : 28
Table of Contents
1 COVID-19 Pipeline of Small and Mid-Cap Companies
1.1 COVID-19 Pipeline of Small and Mid-Cap Companies
1. 2 Analysis of COVID-19 Pipeline by Phase and Type
1.3 Analysis of COVID-19 Pipeline by Market Cap
2 Vaccine Development by Small and Mid-Cap Companies
2.1 COVID-19 Vaccine Pipeline by Phase and Molecule Subtype
2.2 Highest Development Phase COVID-19 Vaccine Pipeline
3 Therapeutic Development by Small and Mid-Cap Companies
3.1 COVID-19 Therapeutic Pipeline by Phase and Molecule Type
3.2 COVID-19 Biologic Therapeutic Pipeline by Phase and Molecule Subtype
3.3 Highest Development Phase COVID-19 Therapeutic Pipeline
4 COVID-19 Deals
4.1 COVID-19-related Partnership Agreements with Small and Mid-Cap Companies
4.2 COVID-19-related Licensing Agreements with Small and Mid-Cap Companies
Key Findings
Appendix
6.1 Glossary
6.2 Methodology
6.3 Related Reports
6.4 About the Authors
6.5 About GlobalData
6.6 Contact Us
Filed in: Pharmaceutical
Publisher : GlobalData